Company intelligence / Profile preview

Revogenex Ireland

Dublin, Leinster, Ireland

Ownership: Private
Development stage: Other

Overview

Revogenex Ireland Limited is a pharmaceutical product development company known for licensing an intravenous formulation of tramadol to Coronado Biosciences (now Avenue Therapeutics) for the U.S. market. The company focuses on developing products that address unmet patient needs using global capabilities and relationships.

Therapeutic areas: Neurology
Modalities: Small Molecules
Industry: Biotech

Partnerships

Coronado Biosciences (now Avenue Therapeutics)

Beyond the preview

Go deeper on Revogenex Ireland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revogenex Ireland.

Explore the full profile